TR
About
Tissue Regenix commercializes innovative technologies in regenerative medicine. The underpinning science was developed over the last decade in the world-leading Institute for Medical and Biological Engineering at the University of Leeds by Professors John Fisher and Eileen Ingham. Tissue Regenix was founded in May 2006, to commercialize innovative technologies in regenerative medicine.
Position in the VCSift Database
- • 3,884 investors in VCSift focus on the healthtech sector.
- • 14 investors are based in York, York, United Kingdom.
Data sourced from 410,343 investor profiles. Updated July 2026.
Investment Focus
- Sectors
- healthtech
- Location
- York, UK
Contact Information
Find more investors like Tissue
Search Investors